1. Home
  2. TNGX vs PAMT Comparison

TNGX vs PAMT Comparison

Compare TNGX & PAMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • PAMT
  • Stock Information
  • Founded
  • TNGX 2014
  • PAMT 1980
  • Country
  • TNGX United States
  • PAMT United States
  • Employees
  • TNGX N/A
  • PAMT N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • PAMT Trucking Freight/Courier Services
  • Sector
  • TNGX Health Care
  • PAMT Industrials
  • Exchange
  • TNGX Nasdaq
  • PAMT Nasdaq
  • Market Cap
  • TNGX 317.4M
  • PAMT 301.4M
  • IPO Year
  • TNGX N/A
  • PAMT 1985
  • Fundamental
  • Price
  • TNGX $1.14
  • PAMT $16.37
  • Analyst Decision
  • TNGX Strong Buy
  • PAMT Hold
  • Analyst Count
  • TNGX 7
  • PAMT 1
  • Target Price
  • TNGX $12.33
  • PAMT $12.50
  • AVG Volume (30 Days)
  • TNGX 532.3K
  • PAMT 42.1K
  • Earning Date
  • TNGX 05-12-2025
  • PAMT 04-23-2025
  • Dividend Yield
  • TNGX N/A
  • PAMT N/A
  • EPS Growth
  • TNGX N/A
  • PAMT N/A
  • EPS
  • TNGX N/A
  • PAMT N/A
  • Revenue
  • TNGX $42,069,000.00
  • PAMT $687,396,000.00
  • Revenue This Year
  • TNGX N/A
  • PAMT $0.61
  • Revenue Next Year
  • TNGX N/A
  • PAMT $10.29
  • P/E Ratio
  • TNGX N/A
  • PAMT N/A
  • Revenue Growth
  • TNGX 15.17
  • PAMT N/A
  • 52 Week Low
  • TNGX $1.11
  • PAMT $11.01
  • 52 Week High
  • TNGX $12.02
  • PAMT $23.70
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 36.06
  • PAMT N/A
  • Support Level
  • TNGX $1.03
  • PAMT N/A
  • Resistance Level
  • TNGX $1.56
  • PAMT N/A
  • Average True Range (ATR)
  • TNGX 0.15
  • PAMT 0.00
  • MACD
  • TNGX -0.01
  • PAMT 0.00
  • Stochastic Oscillator
  • TNGX 17.74
  • PAMT 0.00

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About PAMT PAMT CORP Common Stock

PAMT Corp is a holding company that is engaged in providing truckload dry van carriers transporting general commodities throughout the continental United States, as well as the Canadian provinces of Ontario and Quebec. It has one reportable segment being motor carrier.

Share on Social Networks: